{"id":"https://openalex.org/W2015467896","doi":"https://doi.org/10.1136/bjo.2008.155663","title":"Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy","display_name":"Intravitreal injection of pegaptanib sodium for proliferative diabetic retinopathy","publication_year":2009,"publication_date":"2009-08-18","ids":{"openalex":"https://openalex.org/W2015467896","doi":"https://doi.org/10.1136/bjo.2008.155663","mag":"2015467896","pmid":"https://pubmed.ncbi.nlm.nih.gov/19692371"},"language":"en","primary_location":{"id":"doi:10.1136/bjo.2008.155663","doi":"https://doi.org/10.1136/bjo.2008.155663","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2008.155663","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/93/11/1474.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://bjo.bmj.com/content/bjophthalmol/93/11/1474.full.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"V H Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161463","display_name":"Valley Retina Institute","ror":"https://ror.org/05x1ct167","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210161463"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"V H Gonzalez","raw_affiliation_strings":["Valley Retina Institute, PA, McAllen, TX 78503, USA. research@vritx.com","Valley Retina Institute, PA, 1309 East Ridge Road, Suite 1, McAllen, TX 78503, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valley Retina Institute, PA, McAllen, TX 78503, USA. research@vritx.com","institution_ids":["https://openalex.org/I4210161463"]},{"raw_affiliation_string":"Valley Retina Institute, PA, 1309 East Ridge Road, Suite 1, McAllen, TX 78503, USA","institution_ids":["https://openalex.org/I4210161463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011618136","display_name":"Gian Paolo Giuliari","orcid":"https://orcid.org/0000-0002-6296-3035","observed_orcids":["https://orcid.org/0000-0002-6296-3035"]},"institutions":[{"id":"https://openalex.org/I4210161463","display_name":"Valley Retina Institute","ror":"https://ror.org/05x1ct167","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210161463"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"G P Giuliari","raw_affiliation_strings":["Valley Retina Institute, PA, McAllen, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valley Retina Institute, PA, McAllen, Texas, USA","institution_ids":["https://openalex.org/I4210161463"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069951961","display_name":"Rodolfo M. Banda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161463","display_name":"Valley Retina Institute","ror":"https://ror.org/05x1ct167","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210161463"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R M Banda","raw_affiliation_strings":["Valley Retina Institute, PA, McAllen, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valley Retina Institute, PA, McAllen, Texas, USA","institution_ids":["https://openalex.org/I4210161463"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5037073552","display_name":"David A. Guel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210161463","display_name":"Valley Retina Institute","ror":"https://ror.org/05x1ct167","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210161463"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D A Guel","raw_affiliation_strings":["Valley Retina Institute, PA, McAllen, Texas, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Valley Retina Institute, PA, McAllen, Texas, USA","institution_ids":["https://openalex.org/I4210161463"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I4210161463"],"apc_list":null,"apc_paid":null,"fwci":6.0578,"has_fulltext":true,"cited_by_count":65,"citation_normalized_percentile":{"value":0.96111726,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"93","issue":"11","first_page":"1474","last_page":"1478"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10170","display_name":"Retinal Diseases and Treatments","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11377","display_name":"Retinal and Macular Surgery","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11194","display_name":"Ocular Diseases and Beh\u00e7et\u2019s Syndrome","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2731","display_name":"Ophthalmology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pegaptanib-sodium","display_name":"pegaptanib sodium","score":0.9359999895095825},{"id":"https://openalex.org/keywords/proliferative-diabetic-retinopathy","display_name":"proliferative diabetic retinopathy","score":0.9290000200271606},{"id":"https://openalex.org/keywords/intravitreal-injection","display_name":"intravitreal injection","score":0.9819999933242798},{"id":"https://openalex.org/keywords/panretinal-photocoagulation","display_name":"panretinal photocoagulation","score":0.972000002861023},{"id":"https://openalex.org/keywords/anti-vegf-therapy","display_name":"anti-VEGF therapy","score":0.9169999957084656},{"id":"https://openalex.org/keywords/best-corrected-visual-acuity","display_name":"best-corrected visual acuity","score":0.9259999990463257},{"id":"https://openalex.org/keywords/foveal-thickness","display_name":"foveal thickness","score":0.9380000233650208},{"id":"https://openalex.org/keywords/ocular-side-effects","display_name":"ocular adverse effects","score":0.8019999861717224}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9232741594314575},{"id":"https://openalex.org/C2777512022","wikidata":"https://www.wikidata.org/wiki/Q409935","display_name":"Pegaptanib","level":5,"score":0.9119243621826172},{"id":"https://openalex.org/C118487528","wikidata":"https://www.wikidata.org/wiki/Q161437","display_name":"Ophthalmology","level":1,"score":0.7018599510192871},{"id":"https://openalex.org/C2779829184","wikidata":"https://www.wikidata.org/wiki/Q631361","display_name":"Diabetic retinopathy","level":3,"score":0.690373420715332},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.5209687948226929},{"id":"https://openalex.org/C2778257484","wikidata":"https://www.wikidata.org/wiki/Q555066","display_name":"Visual acuity","level":2,"score":0.5114135146141052},{"id":"https://openalex.org/C2780827179","wikidata":"https://www.wikidata.org/wiki/Q422001","display_name":"Retinal","level":2,"score":0.43610578775405884},{"id":"https://openalex.org/C2778313320","wikidata":"https://www.wikidata.org/wiki/Q550455","display_name":"Retinopathy","level":3,"score":0.432876318693161},{"id":"https://openalex.org/C2777802072","wikidata":"https://www.wikidata.org/wiki/Q413299","display_name":"Bevacizumab","level":3,"score":0.3819579482078552},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.301163911819458},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.27095356583595276},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.21766036748886108},{"id":"https://openalex.org/C2781100027","wikidata":"https://www.wikidata.org/wiki/Q414270","display_name":"Ranibizumab","level":4,"score":0.21712848544120789},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.07351142168045044},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003930","descriptor_name":"Diabetic Retinopathy","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010865","descriptor_name":"Pilot Projects","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011446","descriptor_name":"Prospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015552","descriptor_name":"Injections, Intralesional","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015861","descriptor_name":"Retinal Neovascularization","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015861","descriptor_name":"Retinal Neovascularization","qualifier_ui":"Q000601","qualifier_name":"surgery","is_major_topic":false},{"descriptor_ui":"D017075","descriptor_name":"Laser Coagulation","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":false},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D020533","descriptor_name":"Angiogenesis Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D052157","descriptor_name":"Aptamers, Nucleotide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":4,"locations":[{"id":"doi:10.1136/bjo.2008.155663","doi":"https://doi.org/10.1136/bjo.2008.155663","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2008.155663","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/93/11/1474.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},{"id":"pmid:19692371","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/19692371","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The British journal of ophthalmology","raw_type":"Comparative Study"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.560.1036","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.560.1036","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://bjo.bmj.com/content/93/11/1474.full.pdf","raw_type":"text"},{"id":"pmh:oai:open-archive.highwire.org:bjophthalmol:bjo.2008.155663v1","doi":null,"is_oa":false,"landing_page_url":"http://bjo.bmj.com/cgi/content/short/bjo.2008.155663v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"}],"best_oa_location":{"id":"doi:10.1136/bjo.2008.155663","doi":"https://doi.org/10.1136/bjo.2008.155663","is_oa":true,"landing_page_url":"https://doi.org/10.1136/bjo.2008.155663","pdf_url":"https://bjo.bmj.com/content/bjophthalmol/93/11/1474.full.pdf","source":{"id":"https://openalex.org/S79587146","display_name":"British Journal of Ophthalmology","issn_l":"0007-1161","issn":["0007-1161","1468-2079"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310319945","host_organization_name":"BMJ","host_organization_lineage":["https://openalex.org/P4310319945"],"host_organization_lineage_names":["BMJ"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Ophthalmology","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2015467896.pdf","grobid_xml":"https://content.openalex.org/works/W2015467896.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W40331789","https://openalex.org/W1214250537","https://openalex.org/W1517718326","https://openalex.org/W1526282761","https://openalex.org/W1531031294","https://openalex.org/W1966470033","https://openalex.org/W1972979395","https://openalex.org/W1981614795","https://openalex.org/W1983763042","https://openalex.org/W2002725667","https://openalex.org/W2043863730","https://openalex.org/W2056392188","https://openalex.org/W2098582960","https://openalex.org/W2099927130","https://openalex.org/W2124521298","https://openalex.org/W2128535483","https://openalex.org/W2134954483","https://openalex.org/W2137893922","https://openalex.org/W2146587653","https://openalex.org/W2148290604","https://openalex.org/W2156113162","https://openalex.org/W2171845476","https://openalex.org/W2321462698","https://openalex.org/W2470503025","https://openalex.org/W4248345319","https://openalex.org/W6680034198","https://openalex.org/W7073844601"],"related_works":["https://openalex.org/W7096220912","https://openalex.org/W2982662332","https://openalex.org/W2573768435","https://openalex.org/W2274619029","https://openalex.org/W2900083045","https://openalex.org/W7169794338","https://openalex.org/W3112910910","https://openalex.org/W7162495977","https://openalex.org/W3192636592","https://openalex.org/W7100723449"],"abstract_inverted_index":{"BACKGROUND:":[0],"To":[1],"compare":[2],"the":[3,15,121,192,196],"efficacy":[4],"of":[5,17,68,94,182,187],"intravitreal":[6],"pegaptanib":[7],"(IVP)":[8],"with":[9,33,50,61,172],"panretinal":[10],"laser":[11],"photocoagulation":[12],"(PRP)":[13],"in":[14,46,75,145,153,159],"treatment":[16,45],"active":[18,34,140],"proliferative":[19],"diabetic":[20,183],"retinopathy":[21],"(PDR).":[22],"METHODS:":[23],"A":[24],"prospective,":[25],"randomised,":[26],"controlled,":[27],"open-label,":[28],"exploratory":[29],"study.":[30],"Twenty":[31],"subjects":[32],"PDR":[35],"were":[36,112,170],"randomly":[37],"assigned":[38],"at":[39,124,147,195],"a":[40],"1:1":[41],"ratio":[42],"to":[43,97,164],"receive":[44],"one":[47],"eye":[48],"either":[49],"IVP":[51,110,175],"(0.3":[52],"mg)":[53],"every":[54],"6":[55],"weeks":[56,59,149],"for":[57],"30":[58],"or":[60],"PRP":[62],"laser.":[63],"Efficacy":[64],"endpoints":[65],"included":[66,85],"regression":[67,102,181],"retinal":[69,99,184],"neovascularisation":[70],"(NV),":[71],"changes":[72],"from":[73],"baseline":[74],"best-corrected":[76],"visual":[77],"acuity":[78],"(BCVA)":[79],"and":[80,87,115,136,156,179,194],"foveal":[81],"thickness.":[82],"Safety":[83],"outcomes":[84],"observed":[86],"reported":[88,171],"adverse":[89,168],"events.":[90],"RESULTS:":[91],"In":[92,120],"90%":[93],"randomised":[95],"eyes":[96,111,128,155],"IVP,":[98],"NV":[100,188],"showed":[101,133,138],"by":[103],"week":[104,107,118,125],"3.":[105],"By":[106],"12,":[108],"all":[109],"completely":[113],"regressed":[114],"maintained":[116,190],"through":[117],"36.":[119],"PRP-treated":[122,160],"group,":[123],"36,":[126],"two":[127,132],"demonstrated":[129],"complete":[130],"regression,":[131,135],"partial":[134],"four":[137],"persistent":[139],"PDR.":[141],"The":[142],"mean":[143],"change":[144],"BCVA":[146],"36":[148],"was":[150,189],"+5.8":[151],"letters":[152,158],"pegaptanib-treated":[154],"-6.0":[157],"eyes.":[161],"Only":[162],"mild":[163],"moderate":[165],"transient":[166],"ocular":[167],"events":[169],"pegaptanib.":[173],"CONCLUSIONS:":[174],"produces":[176],"short-term":[177],"marked":[178],"rapid":[180],"NV.":[185],"Regression":[186],"throughout":[191],"study":[193],"final":[197],"visit.":[198]},"counts_by_year":[{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":4},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":7},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2013,"cited_by_count":3},{"year":2012,"cited_by_count":7}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}